InvestorsHub Logo
Followers 10
Posts 997
Boards Moderated 0
Alias Born 01/17/2005

Re: None

Friday, 10/28/2016 11:10:14 PM

Friday, October 28, 2016 11:10:14 PM

Post# of 2794
Factsheet Oct 2016

http://c.eqcdn.com/_a959cbe04805104db28ff6e79a1d5597/actiniumpharma/db/206/775/pdf/ATNM+Fact+Sheet+October+2016.pdf


"Several ongoing physician trials with BC8 mAb, the antibody used in lomab-B, for other indications.
Safety and efficacy data to date indicate that Iomab-B can potentially disrupt the field of BMT"


"The $1.3 billion BMT market in the U.S. is largely unaddressed by novel pharmaceutical companies.
Approximately 150 centers perform approximately 20,000 BMT procedures in the U.S. annually.
Top 30 centers perform greater than 50% of all AML BMT procedures"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATNM News